| IPO Date | May 21, 2026 to May 25, 2026 |
| Listing Date | May 29, 2026 |
| Face Value | ₹ 10 / Share |
| Price Band | ₹ 326 to ₹ 343 / Share |
| Lot Size | 400 Shares |
| Total Issue Size | 6253200 (Aggregating up to 214 ) |
| Fresh Issue | 5940000 (Aggregating up to 204) |
| Offer for Sale | |
| Employee Discount | |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share holding pre issue | 17074999 |
| Share holding post issue | 23328199 |
| Market Maker portion |
Q-Line Biotech IPO opens on May 21, 2026, and closes on May 25, 2026.
| IPO Open Date | May 21, 2026 |
| IPO Close Date | May 25, 2026 |
| Basis of Allotment | May 26, 2026 |
| Initiation of Refunds | May 27, 2026 |
| Credit of Shares to Demat | May 27, 2026 |
| Listing Date | May 29, 2026 |
| Cut-off time for UPI mandate confirmation | -- |
Investors can bid for a minimum of 800 shares and in multiples of 400 shares thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 800 | Rs.274,400 |
| Retail (Max) | 2 | 800 | Rs.274,400 |
| S-HNI (Min) | 3 | 1,200 | Rs.411,600 |
| S-HNI (Max) | 7 | 2,800 | Rs.960,400 |
| B-HNI (Min) | 8 | 3,200 | Rs.1,097,600 |
| HNI (Min) |
| Share Holding Pre Issue | 17074999 |
| Share Holding Post Issue | 23328199 |
Q-Line Biotec IPO comprises a total issue size of 62,53,200 shares. The net offer to the public is 59,40,000 shares, after excluding 3,13,200 shares allotted on a firm basis. Of the Net offer 29,69,200 (49.99%) are allocated to QIB, 8,91,600 (15.01%) allocated to NII 20,79,200 (35.00%) allocated to RII.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 1781200 |
28.48 |
| Market Maker Shares Offered | 313200 |
5.01 |
| Other Shares Offered | |
|
| QIB Shares Offered | 1188000 |
19.00 |
| NII (HNI) Shares Offered | 891600 15.01 |
14.26 |
| bNII > ₹10L | 594400 |
9.51 |
| sNII < ₹10L | 297200 |
4.75 |
| Retail Shares Offered | 2079200 35.00 |
33.25 |
| Employee Shares Offered | |
|
| Total Shares Offered | 6253200 100.00 |
| Bid Date | 2026-05-20 |
| Shares Offered | 1781200 |
| Anchor Portion Size (In Cr.) | 61.10 |
| Anchor lock-in period end date for 50% shares (30 Days) | June 25, 2026 |
| Anchor lock-in period end date for remaining shares (90 Days) | August 24, 2026 |
Incorporated in 2010, Q-Line Biotech Ltd. is engaged in the business of developing, manufacturing and marketing a diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, and distribution/supply of diagnostic equipment for different diagnostic healthcare needs.
The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through our distributor/s majorly to diagnostic service providers, hospitals and medical colleges.
The company's key manufacturing segments include indigenous manufacturing of reagents (Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics, and Others [POC Devices & Rapid Tests]) and supplying/manufacturing of in-vitro diagnostics (IVD) and Pathology equipment & devices.
As of December 31, 2025, the total annual capacity was about 1.4 million kits (Haematology, Clinical Chemistry, Rapid/Elisa) and 1,200 Selectra Machines.
As on March 31, 2026, the company had 362 permanent employees.
Competitive Strengths:
| KPI | Values |
|---|---|
| ROE | 16.88 |
| ROCE | 13.32 |
| Debt/Equity | 1.06 |
| RoNW | 16.88 |
| P/BV | 2.44 |
| PAT Margin (%) | 16.65 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 16.47 | 22.12 |
| P/E (x) | 20.82 | 15.51 |
Saurabh Garg, Amita Garg, Ayush Garg, Ajay Kumar Mahanty and Abhay Agrawal
Q-Line Biotech Ltd. Address 298-281, Transport Nagar Kanpur Road Adjacent Transport Nagar Metro Station Lucknow, Uttar Pradesh, 226012
|